|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$29.26 0.00 (0.00%) as of 4:30 Wed 9/18
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
61,456,000 |
Market
Cap: |
1.80(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$4.9 - $33.99 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile CareDx together with its subsidiaries, is a medicine company focused on the discovery, development and commercialization of diagnostic solutions for transplant patients and caregivers. Co. provides testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey, and is a provider of genomics-based information for transplant patients. Co.'s commercially available testing services consist of AlloSure® Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients, AlloMap® Heart, a solution for heart transplant patients, AlloSure® Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure® Lung.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
130,806 |
130,806 |
133,624 |
214,630 |
Total Sell Value |
$4,334,242 |
$4,334,242 |
$4,353,725 |
$5,363,601 |
Total People Sold |
2 |
2 |
3 |
3 |
Total Sell Transactions |
4 |
4 |
5 |
23 |
End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bell Michael Brian |
Chief Financial Officer |
|
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
89,738 |
|
- |
|
Hagstrom William A |
Director |
|
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
740 |
40,272 |
|
- |
|
Maag Peter |
See Remarks |
|
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
472,037 |
|
- |
|
King Sasha |
Chief Commercial Officer |
|
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
71,500 |
|
- |
|
Snyderman Ralph |
Director |
|
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,197 |
69,996 |
|
- |
|
Yee James P |
Chief Medical Officer |
|
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
63,102 |
|
- |
|
Bickerstaff George |
Director |
|
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,197 |
52,204 |
|
- |
|
Snyderman Ralph |
Director |
|
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
68,799 |
|
- |
|
Hagstrom William A |
Director |
|
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
39,532 |
|
- |
|
Cohen Fred E |
Director |
|
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
37,901 |
|
- |
|
Goldberg Michael |
Director |
|
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
131,123 |
|
- |
|
Bickerstaff George |
Director |
|
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
51,007 |
|
- |
|
Gagnon Neil |
10% Owner |
|
2018-05-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,000 |
878,768 |
|
- |
|
Gagnon Neil |
10% Owner |
|
2018-04-26 |
4 |
B |
$9.42 |
$95,481 |
I/I |
10,136 |
965,894 |
1.5 |
- |
|
Goldberg Michael |
Director |
|
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,258 |
126,123 |
|
- |
|
Snyderman Ralph |
Director |
|
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,221 |
63,799 |
|
- |
|
Bickerstaff George |
Director |
|
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,221 |
46,007 |
|
- |
|
Hagstrom William A |
Director |
|
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,373 |
34,532 |
|
- |
|
Maag Peter |
See Remarks |
|
2018-03-27 |
4 |
AS |
$7.87 |
$118,035 |
D/D |
(15,000) |
272,037 |
|
- |
|
Maag Peter |
See Remarks |
|
2018-03-20 |
4 |
OE |
$0.55 |
$27,400 |
D/D |
50,000 |
287,037 |
|
- |
|
Maag Peter |
See Remarks |
|
2018-02-14 |
4 |
OE |
$0.55 |
$49,286 |
D/D |
89,938 |
237,037 |
|
- |
|
Yee James P |
Chief Medical Officer |
|
2018-01-29 |
4 |
D |
$6.25 |
$5,031 |
D/D |
(805) |
43,102 |
|
- |
|
Nelles Mitchell J |
Chief Operating Officer |
|
2018-01-29 |
4 |
D |
$6.25 |
$5,031 |
D/D |
(805) |
79,639 |
|
- |
|
Maag Peter |
See Remarks |
|
2018-01-29 |
4 |
D |
$6.25 |
$9,063 |
D/D |
(1,450) |
147,099 |
|
- |
|
Sninsky John Joseph |
Chief Scientific Officer |
|
2018-01-29 |
4 |
D |
$6.25 |
$5,031 |
D/D |
(805) |
22,309 |
|
- |
|
821 Records found
|
|
Page 24 of 33 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|